FDA Approves Emergency Authorization For COVID-19 Saliva Test

Yale University developed a new coronavirus test called Saliva Direct, which is less invasive and cheaper than nasal swabs. Although not yet peer-reviewed, it shows similar accuracy to nasal tests. The FDA has granted emergency authorization, and the NBA has used it for daily testing. Saliva Direct could be a significant advancement in public health testing, costing around $10 per sample.

What is the main advantage of the Saliva Direct test compared to nasal swab tests?

• It is more expensive.

• It is less invasive.

• It takes longer to get results.

• It requires more equipment.

What has the FDA said about saliva tests in general?

• They are not suitable for emergency use.

• They have shown varied results.

• They are always more accurate than nasal swabs.

• They have shown consistent results.

Which organization partnered with Yale for testing as the league restarted its season?

• NHL

• NBA

• MLB

• NFL

What is the expected cost per sample for the Saliva Direct test?

• $10

• $5

• $50

• $20

What potential does the Saliva Direct test have according to Yale?

• To replace all other tests

• To be used on a larger scale to protect public health

• To be used only in sports leagues

• To be more expensive than other tests